设计的卷轴-卷轴HIF1α蛋白质域模拟器
Dustin Britton1, Olga Katsara2, Orin Mishkit3,4
1Department of Chemical and Biomolecular Engineering, New York University Tandon School of Engineering, Brooklyn, New York, 11201, USA. montclare@nyu.edu.
研究人员开发了一种新型蛋白质 (HIF1α-MAP),该蛋白质针对低氧瘤微环境. 这种药物表现出对p300的高结合亲和力,降低低氧诱导基因的调节,并在体内向瘤.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 有针对性的抗癌疗法旨在提高药物疗效和诊断.
- 瘤微环境 (TME) 向为通用药物提供了瘤无关的方法.
- 缺氧诱导因子1 (HIF1) 对瘤适应缺氧至关重要;抑制其与p300的相互作用显示出治疗前景.
研究的目的:
- 开发一种针对低氧瘤微环境的新型治疗剂.
- 创建一个基于HIF1α和软骨寡合基质蛋白 (COMPcc) 的多价值组合蛋白 (MAP).
- 评估开发的药物的结合亲和力,基因调节和体内向能力.
主要方法:
- 使用多价值组装蛋白 (MAP) 策略.
- 将COMPcc域与HIF1α C终端交换激活域 (C-TAD) 的关键残留物融合在一起.
- 生成HIF1α-MAP (H-MAP) 并评估其结合亲和力,基因降调和体内瘤向.
主要成果:
- HIF1α-MAP (H-MAP) 显示出与p300的皮科莫尔结合亲和力.
- 该药物成功降低了对缺氧诱导基因的调控.
- 在体内,H-MAP表现出有效的瘤向能力.
结论:
- HIF1α-MAP是HIF1-p300相互作用的强有力的抑制剂.
- 开发的药物显示出作为一种通用瘤向治疗的承诺.
- 这种方法利用缺氧TME用于针对性抗癌药物开发.
更多相关视频
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
12:19Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
相关概念视频
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Single-Strand DNA Binding Proteins
Molecular Chaperones and Protein Folding
The...
Covalently Linked Protein Regulators
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
